Fernandez M - Search Results

1

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.

Fernandez M, Mejias M, Garcia-Pras E, Mendez R, Garcia-Pagan JC, Bosch J. Fernandez M, et al. Hepatology. 2007 Oct;46(4):1208-17. doi: 10.1002/hep.21785. Hepatology. 2007. PMID: 17654489

2

Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats.

Morales J, Moitinho E, Abraldes JG, Fernández M, Bosch J. Morales J, et al. Among authors: fernandez m. Hepatology. 2003 Dec;38(6):1378-83. doi: 10.1016/j.hep.2003.09.023. Hepatology. 2003. PMID: 14647048

3

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Fernandez M, et al. Gastroenterology. 2004 Mar;126(3):886-94. doi: 10.1053/j.gastro.2003.12.012. Gastroenterology. 2004. PMID: 14988842

4

Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.

Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodés J, Bosch J. Fernandez M, et al. J Hepatol. 2005 Jul;43(1):98-103. doi: 10.1016/j.jhep.2005.02.022. Epub 2005 Apr 25. J Hepatol. 2005. PMID: 15893841

5

Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats.

Angermayr B, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J, Fernandez M. Angermayr B, et al. Among authors: fernandez m. J Hepatol. 2006 Jun;44(6):1033-9. doi: 10.1016/j.jhep.2005.09.021. Epub 2005 Nov 8. J Hepatol. 2006. PMID: 16458992

6

The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.

Matei V, Rodríguez-Vilarrupla A, Deulofeu R, Colomer D, Fernández M, Bosch J, Garcia-Pagán JC. Matei V, et al. Among authors: fernandez m. Hepatology. 2006 Jul;44(1):44-52. doi: 10.1002/hep.21228. Hepatology. 2006. PMID: 16799985

7

NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.

Angermayr B, Fernandez M, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J. Angermayr B, et al. Among authors: fernandez m. Gut. 2007 Apr;56(4):560-4. doi: 10.1136/gut.2005.088013. Epub 2006 Jul 19. Gut. 2007. PMID: 16854998 Free PMC article.

8

The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.

Mejias M, Garcia-Pras E, Tiani C, Bosch J, Fernandez M. Mejias M, et al. Among authors: fernandez m. J Cell Mol Med. 2008 Sep-Oct;12(5A):1690-9. doi: 10.1111/j.1582-4934.2008.00218.x. Epub 2008 Jan 11. J Cell Mol Med. 2008. PMID: 18194463 Free PMC article.

9

Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension.

Tiani C, Garcia-Pras E, Mejias M, de Gottardi A, Berzigotti A, Bosch J, Fernandez M. Tiani C, et al. Among authors: fernandez m. J Hepatol. 2009 Feb;50(2):296-305. doi: 10.1016/j.jhep.2008.09.019. Epub 2008 Dec 4. J Hepatol. 2009. PMID: 19070926

10

Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.

Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M. Mejias M, et al. Among authors: fernandez m. Hepatology. 2009 Apr;49(4):1245-56. doi: 10.1002/hep.22758. Hepatology. 2009. PMID: 19137587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,756 results

Search Page

Filters